Next Financial Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Next Financial Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$2K	–	2837
2021 Q2	$2K	Hold	100	–	–	﹤0.01%	2466
2021 Q1	$2K	Buy	+100	New	+$2.79K	﹤0.01%	2350
2020 Q1	–	Sell	-1,204	Closed	-$149K	–	2470
2019 Q4	$149K	Buy	+1,204	New	+$108K	0.02%	795
2016 Q1	–	Sell	-20	Closed	-$2K	–	1893
2015 Q4	$2K	Sell	20 -10	-33%	-$1.69K	﹤0.01%	1634
2015 Q3	$4K	Hold	30	–	–	﹤0.01%	1507
2015 Q2	$7K	Hold	30	–	–	﹤0.01%	1395
2015 Q1	$8K	Hold	30	–	–	﹤0.01%	1351
2014 Q4	$5K	Hold	30	–	–	﹤0.01%	1522
2014 Q3	$7K	Buy	+30	New	+$7.65K	﹤0.01%	1951

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Next Financial Group's ICPT Position: Q3 2021 in Review

Next Financial Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2021, closing a stake of 100 shares — an estimated $2K sold.

Next Financial Group first reported a position in ICPT in Q3 2014 and held it in 9 quarters. The position peaked at $149K in Q4 2019. 139 funds tracked by Wall St. Rank hold ICPT as of Q3 2021.

Next Financial Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Next Financial Group sold 100 Intercept Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2K.
Next Financial Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 9 quarters.
Next Financial Group's Intercept Pharmaceuticals, Inc. position peaked at $149K in Q4 2019.
139 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2021.

Based on Next Financial Group's 13F filing for Q3 2021, filed 15 Oct 2021.